510(k) Report

510(k) · Cleared

Cleared

Hemosil D-Dimer HS

K050544510(k) TraditionalCleared Apr 26, 200555-day reviewClass II21 CFR 864.7320

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Instrumentation Laboratory CO · DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control

Cleared on Apr 26, 2005 as substantially equivalent to K972696 (Instrumentation Laboratory CO, 1997) after a 55-day review. Its family tree reaches back 2 generations to 1995.

Decided
Apr 26, 2005
Review
55 days
Class
Class II
Product code
DAP
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K945642 (1995). No later device cites it as a predicate yet.

  1. Root · 2 generations backK945642 Agen Dimertest Gold EiaAgen Biomedical, Ltd. · 1995
  2. 1 generation backK972696 IL Test D-DimerInstrumentation Laboratory CO · 1997
  3. This deviceK050544 Hemosil D-Dimer HSInstrumentation Laboratory CO · 2005
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K945642Agen Dimertest Gold EiaAgen Biomedical, Ltd.1995—
−1K972696IL Test D-DimerInstrumentation Laboratory CO1997—
0 (this device)K050544Hemosil D-Dimer HSInstrumentation Laboratory CO2005—
FIG. 1 — Lineage of K050544, 1995–2005Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DAP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DAP device

  1. #1 K253985 INNOVANCE® D-Dimer 2.0 (SMN 10873803)score 13.0 · 5 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K972696IL Test D-Dimer
Summary page 1
…um, Control Device Class: Class TI Regulation No.: 864.7320 Product Code: DAP Panel: Hematology Predicate Device: HemosiL D-Dimer K972696 Device Intended Use / Description: HemosIL D-Dimer HS is an automated latex enhanced immunoassay for the quantitative determinat…
Instrumentation Laboratory CO1997—

Also cleared against K972696: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 10 years and passes through 2 companies; a new generation was cleared every 7.5 years on median.
  • None of the 2 ancestors has a recall.
  • 4 other devices also cite its predicate K972696.

How does its category compare?

All DAP devices

DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DAP

1in 2017

2007: 22008: 32009: 12010: 22011: 12012: 12014: 12015: 12016: 22017: 12026 (partial year): 1
2007high 3 (2008) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DAP

127in 2008

2008: 127 days median
2007high 127 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DAP

2in 2025

2015: 12021: 12025: 2
2007high 2 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DAP

2in 2025

2007: 42008: 102009: 132010: 92011: 142012: 102013: 82014: 92015: 382016: 202017: 172018: 52019: 92020: 112021: 72022: 302023: 42024: 12025: 2
2007high 38 (2015) · low 1 (2024)2025

MAUDE reports naming product code DAP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—04
20083127010
20091—013
20102—09
20111—014
20121—010
20130—08
20141—09
20151—138
20162—020
20171—017
20180—05
20190—09
20200—011
20210—17
20220—030
20230—04
20240—01
20250—22
20261—0—

What is it indicated for?

HemosIL D-Dimer HS is an automated latex enhanced immunoassay for the quantitative determination of D-Dimer in human citrated plasma on the ACL TOP as an aid in the diagnosis of venous thromboembolism (VTE) [deep venous thrombosis (DVT) and pulmonary embolism (PE)].

For in vitro diagnostic use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K050544: Hemosil D-Dimer HS.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K050544

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026